ASAM commended Senator Elizabeth Warren, Representatives Elijah Cummings, and all original co-sponsors for introducing the CARE Act of 2019. Modeled on successful, bipartisan legislation passed in 1990 to address the HIV/AIDS epidemic, the CARE Act would authorize $100 billion in federal funding over the next decade to states, local governments, and other organizations and institutions to support substance use disorder treatment programs, improve training for addiction treatment professionals in communities across the US, and expand access to treatments that meet national standards and are proven to save lives. 

ASAM joined 145 members of the Coalition to Stop Opioid Overdose and other organizations in sending a letter voicing support for the CARE Act of 2019. This legislation 2019 would provide $100 billion in federal funding over the next ten years to support federal research and programs to prevent drug use while expanding access to prevention, harm reduction, addiction treatment, mental health services, and recovery support services.

ASAM joins over 75 organizations, including the Association of American Medical Colleges, in sending a letter urging members of Congress to cosponsor The Resident Physician Shortage Reduction Act of 2019 (S.348, H.R. 1763).

ASAM joined members of the Tobacco Partners Coalition in sending a letter responding to a request for comment on an FDA draft guidance on certain deemed tobacco products

ASAM today commended a bipartisan group of US Senators calling for strategic investments to increase the ranks of qualified, well-trained addiction treatment professionals in high-need communities across the United States.

An analysis of the impact of a federal judge's rulings striking down Medicaid work requirement programs in Kentucky and Arkansas.

On April 3, the Board of Directors of the American Society of Addiction Medicine (ASAM) approved a new policy statement: Public Policy Statement on the Ethical Use of Drug Testing in the Practice of Addiction Medicine. This Policy Statement includes recommendations on the clinical use of drug testing, appropriateness of presumptive testing, and the responsibilities of clinicians when testing for drugs.

The Partnership to Amend 42 CFR Part 2 issued a statement in response to the introduction of identical bipartisan bills in both the House and Senate. The Overdose Prevention and Patient Safety Act, “OPPS Act”, was introduced by Congressmen Earl Blumenauer (D-OR) and Markwayne Mullin (R-OK) and the Protecting Jessica Grubb’s Legacy Act, “Legacy Act”, was introduced by Senators Shelley Moore Capito (R-WV) and Joe Manchin (D-WV).